Replies to post #41544 on Biotech Values

[fid]

Any thoughts on the Alexion results and how they relate to MPH?

http://www.biospace.com/news_story.aspx?StoryID=14315320&full=1

Although they showed statistical significance in several MI analysis, there was really no effect in mortality? Thoughts.

Also of note it appears that they had less events in their study 11.8% as compared to roughly 17% in the MPH Phase II study (50/300). Any thoughts as to why?